Skip to main content

Table 4 Utilization outcomes attributable to inappropriate antifungal treatment

From: Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study

Outcome Point estimate 95% CI P value
Excess hospital LOS (days) following onset of CBSI* 7.7 0.6-13.5 0.015
Excess hospital costs ($)† $13,398 $1,060-$26,736 0.033
  1. Based on generalized linear models with gamma distribution
  2. *Generalized linear model, adjusted for all covariates with p < 0.2 in the univariate analysis plus age, APACHE II score, need for mechanical ventilation and need for pressors; manual backwards elimination to arrive at most parsimonious model
  3. †Generalized linear model, adjusted for all covariates with p < 0.2 in the univariate analysis plus age and time from hospital admission to CBSI onset, APACHE II score, need for mechanical ventilation and need for pressors; manual backwards elimination to arrive at most parsimonious model